Jim Datin

Jim Datin

Chief Executive Officer at
BioAgilytix Europe GmbH
63 year
Health Technology
Finance
Technology Services

Profile

Mr. Jim A. Datin is an Operating Partner at GHO Capital Partners LLP, a Chief Executive Officer & Director at BALX Holdings LLC and a Co-Managing Director at BioAgilytix Europe GmbH.
He is on the Board of Directors at The North Carolina Biotechnology Center, BALX Holdings LLC, Hepatitis B Foundation and Life Sciences Pennsylvania.
Mr. Datin was previously employed as an Independent Director by OraSure Technologies, Inc., an Independent Director by FSD Pharma, Inc., a Non-Executive Director by BioAgilytix Labs LLC, an Independent Director by NuPathe, Inc., a Vice Chairman by University City Science Center, an Executive Vice President & Managing Director by Safeguard International Management LLC, an EVP & Managing Director-Life Sciences Group by Safeguard Scientifics, Inc., a Chairman by Clarient, Inc., a Chief Executive Officer by TouchPoint Solutions, a Group President by Dendrite International, Inc., a Group Director-Corporate Business Strategy by GlaxoSmithKline, Inc., a Chief Executive Officer by Golden Land Bhd., a Director-International Business by Baxter Corp., a Member by Ben Franklin Technology Partners /Ventures/, a Chairman by Laureate Biopharmaceutical Services, Inc., a Director-International Business by Merck KGaA, and a Group Director by Smithkline Beckman Corp.
He also served on the board at Acelerate, Inc., Celerant Consulting, Inc., Intralinks Holdings, Inc., NovaSom, Inc., Putney, Inc., Rubicor Medical, Inc., Sotera Wireless, Inc. and Ventaira Pharmaceuticals, Inc. He received his undergraduate degree from Marshall University, an undergraduate degree from The Wharton School of the University of Pennsylvania and an MBA from the University of New Haven.

Jim Datin active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member -
Director/Board Member 01/01/2017
Chief Executive Officer -
Chief Executive Officer -
Private Equity Investor 01/01/2023

Former positions of Jim Datin

CompaniesPositionEnd
ORASURE TECHNOLOGIES, INC. Director/Board Member 01/06/2024
Chief Executive Officer 16/06/2022
QUANTUM BIOPHARMA LTD. Director/Board Member 30/04/2021
░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Jim Datin's experience

Training of Jim Datin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

70

1st degree connections

34

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies34

Finance

Technology Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Services

Technology Services

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Technology Services

Miscellaneous

Technology Services

Finance

Finance

Commercial Services

Health Technology

Commercial Services

Commercial Services

Consumer Services

Finance

Health Technology

Health Technology

Commercial Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!